Funding for this research was provided by:
United States Agency for International Development (AID-OAA-14-00060)
Received: 20 April 2019
Accepted: 9 June 2019
First Online: 26 June 2019
Ethics approval and consent to participate
: The protocol was approved by the National Health Sciences Research Committee of Malawi (NHSRC) and the Biomedical Institutional Review Board (IRB) of the University of North Carolina at Chapel Hill. All research activities adhere to Malawian and US ethical standards for research in human subjects. To ensure protection of patients’ identities and confidentiality, the evaluation uses routinely collected, de-identified clinical data to assess this treatment program. None of the patients will be identified in any reports or publications about this evaluation. All data will be analysed collectively so that information from any one patient will remain anonymous. Written informed consent will be obtained from every participant.
: Not applicable.
: The authors declare that they have no competing interests.